Adenosine Signaling in the Tumor Microenvironment

Luca Antonioli1, Matteo Fornai2, Carolina Pellegrini3

  • 1Unit of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. luca.antonioli@medmcs.unipi.it.

Insights

Extracellular adenosine, produced by dying cancer cells, creates an immunosuppressed tumor environment. Targeting adenosine receptors offers novel therapeutic strategies against cancer.

Area of Science:

  • Immunology
  • Oncology
  • Biochemistry

Background:

  • Extracellular adenosine, generated by the CD39/CD73 enzyme axis from ATP released by dying cancer cells, promotes an immunosuppressed tumor microenvironment.
  • This immunosuppression favors tumor onset and progression, creating immune-privileged sites for cancer cell survival.

Purpose of the Study:

  • To elucidate the role of extracellular adenosine in modulating immune and non-immune cells within the tumor microenvironment.
  • To explore adenosine signaling pathways as potential targets for novel cancer therapeutic strategies.

Main Methods:

  • Analysis of adenosine production and degradation pathways in the tumor environment.
  • Investigation of adenosine's interaction with G-protein-coupled receptors (A1, A2A, A2B, A3) on various cell types.
  • Evaluation of adenosine's impact on immune cell function and tumor progression.

Main Results:

  • Adenosine signaling through its receptors plays a critical role in shaping the tumor microenvironment.
  • The CD39/CD73 enzyme axis is central to adenosine generation, contributing to immune suppression.
  • Adenosine influences both immune and non-immune cells, impacting cancer cell proliferation.

Conclusions:

  • Extracellular adenosine is a key mediator of immunosuppression in the tumor microenvironment.
  • Targeting adenosine metabolism or its receptors presents a promising avenue for developing innovative cancer therapies.
  • Understanding adenosine's multifaceted role is crucial for overcoming immune evasion in cancer.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.5K
Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
66.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K